Weekly adriamycin® vs. 4-epidoxorubicin every second week in advanced breast cancer. A randomized trial
- 1 January 1990
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 26 (1) , 45-48
- https://doi.org/10.1016/0277-5379(90)90255-r
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pharmacokinetics of weekly low dose doxorubicinEuropean Journal of Cancer and Clinical Oncology, 1989
- Weekly Adriamycin versus VAC in advanced breast cancer. A randomized trialEuropean Journal of Cancer and Clinical Oncology, 1986
- Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.Journal of Clinical Oncology, 1986
- Comparative pharmacokinetic study of adriamycin and 4'epi-adriamycin after their simultaneous intravenous administrationEuropean Journal of Clinical Pharmacology, 1986
- A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.Journal of Clinical Oncology, 1985
- Pharmacokinetic study of IV infusions of adriamycinEuropean Journal of Clinical Pharmacology, 1985
- Assessment of response to therapy in advanced breast cancer.A project of the programme on clinical oncology of the International Union against Cancer, Geneva, SwitzerlandCancer, 1977
- STUDIES ON ADRIAMYCIN USING A WEEKLY REGIMEN DEMONSTRATING ITS CLINICAL EFFECTIVENESS AND LACK OF CARDIAC TOXICITY1976